First Financial Equity Corporation’s Allergan plc AGN Stock Holding History

First Financial Equity Corporation’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$465K	Buy	+1,931	New	+$450K	0.08%	228

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

First Financial Equity Corporation's AGN Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Allergan plc (AGN) in Q1 2017: 1,931 shares worth $465K. The stake represents 0.08% of the portfolio and ranks #228 among its holdings.

1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

First Financial Equity Corporation held 1,931 shares of Allergan plc worth $465K as of Q1 2017.
Allergan plc was a new First Financial Equity Corporation position in Q1 2017.
Allergan plc made up 0.08% of First Financial Equity Corporation's portfolio in Q1 2017, its #228 holding.
1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.